Orris

A patient with 12 days of fever and joint pain and generalized rash after 5th days of fever total count 1300 esr 32 crp positive serum ferritin 1258

Reading File
Finding Sources
Finding Sources
Searching PubMed

adult onset Still disease diagnosis ferritin

Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have all the information needed for a thorough, well-cited answer.

Diagnosis: Adult-Onset Still's Disease (AOSD)

This clinical picture is a textbook presentation of Adult-Onset Still's Disease (AOSD) - a systemic autoinflammatory disorder of unknown etiology.

Why This Fits

Patient's FindingAOSD Feature
12 days of high feverQuotidian (daily) fever ≥39°C, often in late afternoon/evening spikes
Generalized rash appearing on day 5 of feverEvanescent salmon-pink macular/maculopapular rash coinciding with fever spikes
Joint pain / arthritisPolyarthritis (knees, wrists, ankles most common)
Total count 1,300 (leukopenia)Atypical - AOSD classically causes leukocytosis ≥10,000 with ≥80% PMNs, but see note below
ESR 32 (mildly elevated)ESR elevated in 85% of AOSD patients
CRP positiveCRP elevated in 93% of AOSD patients
Serum ferritin 1,258 (markedly elevated)Highly characteristic - often >2000 ng/mL in AOSD; even moderate elevation is significant
Note on leukopenia (WBC 1,300): This is an important red flag. AOSD classically causes leukocytosis, not leukopenia. A WBC of 1,300 with this clinical picture should immediately raise concern for:
  • Macrophage Activation Syndrome (MAS/HLH) - a life-threatening complication of AOSD occurring in ~5-15% of cases; manifests with fever, cytopenias, hyperferritinemia, and hepatosplenomegaly
  • SLE - which causes leukopenia, rash, fever, and arthritis
  • Viral infections (EBV, CMV, dengue) which must be excluded before diagnosing AOSD

Diagnostic Criteria for AOSD

Yamaguchi Criteria (requires ≥5, with ≥2 major, and exclusion criteria met):
Major:
  1. Fever ≥39°C lasting ≥1 week ✓
  2. Arthralgia lasting ≥2 weeks ✓ (12 days)
  3. Typical salmon-pink rash with fever spikes ✓
  4. Leukocytosis ≥10,000 + ≥80% PMNs - NOT met (leukopenia here)
Minor:
  • Pharyngitis/sore throat
  • Lymphadenopathy/splenomegaly
  • Elevated liver enzymes
  • Negative RF and ANA
Exclusion criteria must be absent: no infection (especially sepsis, EBV), no malignancy (lymphoma), no other inflammatory disease.
Fautrel Criteria (≥4 major, or ≥3 major + 2 minor) - does not require leukocytosis and includes glycosylated ferritin ≤20% as a major criterion, making it useful when leukocytosis is absent.

The Ferritin is Key

  • Ferritin of 1,258 is significantly elevated and is highly characteristic of AOSD
  • In healthy individuals, 50-80% of ferritin is glycosylated; this drops to <20% in AOSD
  • If glycosylated ferritin fraction can be measured, a value ≤20% strongly supports AOSD and is a Fautrel major criterion
  • Ferritin >500 with fever + rash + arthritis should always prompt AOSD workup

Immediate Workup to Order

  1. Blood culture - rule out sepsis/bacteremia
  2. EBV, CMV, dengue serology - mandatory exclusion in AOSD
  3. ANA, anti-dsDNA, RF, anti-CCP - rule out SLE/RA
  4. LFTs, LDH - hepatic involvement in AOSD; also elevated in MAS
  5. Triglycerides, fibrinogen - if MAS suspected (triglycerides high, fibrinogen low in MAS)
  6. Peripheral smear + bone marrow - if WBC 1,300 persists; consider HLH workup (ferritin >10,000 is highly suggestive of HLH)
  7. Glycosylated ferritin fraction - specific for AOSD
  8. Repeat CBC - confirm leukopenia; check platelet trend

Management

Step 1 - Acute phase:
  • NSAIDs (enteric-coated aspirin) - first line for mild disease, but response rate only 20-25%
  • Corticosteroids - first-line for moderate-severe disease; often required given poor NSAID response
Step 2 - Steroid-sparing / refractory:
  • Methotrexate - most commonly used DMARD
  • Hydroxychloroquine, sulfasalazine, azathioprine
Step 3 - Biologic agents (for resistant/chronic cases):
  • Anakinra (anti-IL-1) - increasingly used early in severe disease
  • Canakinumab (anti-IL-1β) - used in refractory cases
  • Tocilizumab (anti-IL-6) - shown promise especially in chronic/articular pattern
  • Anti-TNF agents (etanercept, adalimumab)
If MAS/HLH present:
  • High-dose IV corticosteroids
  • Cyclosporine, etoposide for refractory MAS
  • IV immunoglobulins

Clinical Course Patterns

AOSD follows one of three patterns:
  1. Monocyclic - single episode, resolves completely (~20%)
  2. Polycyclic - recurrent flares with remissions (~30%)
  3. Chronic - persistent articular disease (~50%), higher risk of joint destruction
Sources:
  • Fitzpatrick's Dermatology, 9e - AOSD criteria, lab findings, histopathology
  • Fuster and Hurst's The Heart, 15e - AOSD overview and treatment
  • Frameworks for Internal Medicine - FUO differential, ferritin >2000 and AOSD
  • De Matteis A et al. Ann Rheum Dis 2024 (PMID 39317414) - 2023 EULAR/PReS recommendations confirming sJIA and AOSD as the same disease spectrum
The leukopenia in this patient makes it imperative to rule out MAS/HLH before confirming AOSD. A rising ferritin trend, cytopenias, and hyperferritinemia together should prompt urgent MAS workup.
This is a shared conversation. Sign in to Orris to start your own chat.